<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

“Using this approach to target and reprogram immune cells represents an innovative application for cardiovascular medicine and opens up exciting opportunities for developing novel therapeutics,” Ronald Vagnozzi and Timothy McKinsey, heart researchers at the University of Colorado Anschutz Medical Campus who were not involved in the study, write in a joint email to The Scientist.